Ellanse

Ellansé is an injectable implant whose active material is polycaprolactone, smooth PCL microspheres suspended in a carrier gel that the manufacturer describes as a carboxymethylcellulose-based gel. It is manufactured in the Netherlands and distributed by Sinclair, and its CE-marked intended use is subdermal implantation in the face for the correction of wrinkles and signs of facial ageing. Kaiteki uses it within its bio-stimulator treatment, alongside other bio-stimulator materials.

What distinguishes Ellansé from a hyaluronic acid filler is the two-part behaviour the manufacturer describes: the carrier gel provides support when it is placed, while the PCL microspheres remain and act as a stimulus for the skin's own collagen response as they are gradually resorbed. So part of the intended change is immediate and part of it develops over months. Whether Ellansé, another bio-stimulator or a filler suits your concern is a clinical judgement your doctor makes at an in-person consultation.

Polycaprolactone is a synthetic, bioresorbable polymer already used in absorbable medical implants and sutures. In Ellansé the PCL is formed into uniform microspheres held in the carrier gel. The gel component is absorbed over time, leaving the microspheres in place; as those are gradually broken down and cleared, they act as a scaffold and stimulus around which the body forms its own collagen. That is why the manufacturer frames Ellansé as regenerative rather than purely volumising: the later part of the effect is your tissue, not the product.

Unlike hyaluronic acid fillers, polycaprolactone has no dissolving agent: it is bioresorbable and is cleared by the body over time rather than reversed on demand.

Ellansé is supplied as a range of variants (identified by the manufacturer as Ellansé-S through to Ellansé-E) which differ in how long the PCL microspheres take to be resorbed. The manufacturer describes the range as offering sustained duration from around twelve months at the shorter end up to several years at the longest, but individual response varies and duration is not guaranteed. Which variant is used, where it is placed and how much is used are decisions for the treating doctor after assessing your face, not something to choose from a website. Results develop gradually and vary between individuals.

Within Kaiteki's bio-stimulator treatment, Ellansé is commonly considered where the concern combines loss of structural support with declining skin quality. It is not suitable for everyone, and a consultation determines whether it is appropriate for you.

It is often compared with Sculptra. Both are bio-stimulators, but the material differs: Ellansé's polycaprolactone microspheres sit in a carrier gel that the manufacturer describes as giving support when placed, while Sculptra's poly-L-lactic acid is reconstituted before use and is intended to act more purely as a gradual collagen stimulus over a course of sessions. Which is appropriate for your concern is decided by your doctor at consultation.

Concerns it is typically directed at include:

Ellansé is aimed at adults who want a staged, structural approach and understand that part of the change appears later rather than immediately. Because the mechanism is biological rather than light-based, skin tone is not a limiting factor in the way it can be for laser treatments, so it is used across a range of skin tones including Asian skin. Your facial anatomy, how much support has been lost and any previous injectable work in the area all influence whether it is appropriate.

Because polycaprolactone cannot be dissolved the way hyaluronic acid can, careful assessment before treatment matters more, not less. Ellansé is not appropriate for anyone with a known hypersensitivity to its components, and it is not used where there is active infection or inflammation at or near the intended site. It is not used in pregnancy or while breastfeeding. Bleeding disorders and blood-thinning medication, autoimmune or connective-tissue conditions, a history of keloid or hypertrophic scarring, and previous permanent or semi-permanent implants in the same area are all relevant considerations. Please share your full medical history, medication list and any past injectable or surgical treatments at consultation.

The visit starts with a doctor consultation and facial assessment, covering your concern, your medical history, which product category is appropriate and the realistic time course. If Ellansé is appropriate, the doctor selects the variant and plan, the skin is cleansed and prepared, and topical or local anaesthetic is used for comfort. The injection is carried out according to the assessed plan; the appointment as a whole is usually short, with most of the time spent on assessment and aftercare rather than injecting.

The doctor may shape and massage the area afterwards and will explain aftercare. Many plans are built around a single treatment session with a review afterwards, though some people need more than one depending on the assessment and how the area responds. Your doctor will explain what to expect for you and when to come back for review.

Downtime is usually limited, but this varies. Swelling, redness, tenderness or bruising at the injection sites is common in the first days and typically settles; bruising can take longer to fade in some people, so it is worth planning around any upcoming event.

Your doctor will give aftercare guidance for your case, which commonly includes avoiding pressure, vigorous massage, facial treatments, heat and strenuous exercise on the area for a short period, plus any specific instructions for the treated region. Because part of the intended change develops over months, attending the review appointment matters, and anything unexpected should be raised with the clinic promptly rather than left.

As with any injectable procedure, Ellansé carries risks, which are explained during consultation. The manufacturer lists possible effects including pain, swelling, redness, bruising, inflammation, infection, hypersensitivity reactions and nodule or lump formation, and recognises rare but serious complications associated with inadvertent intravascular injection during facial filler procedures. These are uncommon when the treatment is appropriately selected and performed by a trained doctor working to an assessed plan, and your doctor will explain which symptoms to report and how quickly.